Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Effect of Nicotine on Chronic Pelvic Pain

Phase 4

Completed

Conditions: Pelvic Pain

Interventions: Drug: Placebo
Drug: Nicotine (5 mg)
Drug: Nicotine (10 mg)

First Posted Date: 2007-02-27

Last Posted Date: 2018-08-14

Lead Sponsor: Columbia University

Target Recruit Count: 20

Registration Number: NCT00440505

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Nicotine Patch as an Analgesic Adjuvant After Surgery

Phase 4

Completed

Conditions: Pain

Interventions: Drug: nicotine patch
Drug: placebo

First Posted Date: 2007-02-27

Last Posted Date: 2021-10-21

Lead Sponsor: Columbia University

Target Recruit Count: 68

Registration Number: NCT00440830

Locations: 🇺🇸
Columbia University Irving Medical Center / New York Presbyterian, New York, New York, United States

Documenting a Learning Curve and Test-retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery

Not Applicable

Completed

Conditions: Education

Interventions: Other: LapSim training

First Posted Date: 2007-02-15

Last Posted Date: 2012-11-21

Lead Sponsor: Columbia University

Target Recruit Count: 29

Registration Number: NCT00435630

Locations: 🇺🇸
Columbia University College of Physicians and Surgeons, New York, New York, United States

Primary Hyperparathyroidism: Non-classical Manifestations

Completed

Conditions: Primary Hyperparathyroidism

First Posted Date: 2007-02-08

Last Posted Date: 2015-03-09

Lead Sponsor: Columbia University

Target Recruit Count: 58

Registration Number: NCT00432939

Locations: 🇺🇸
Metabolic Bone Diseases Unit, New York, New York, United States

The Stroke Warning Information and Faster Treatment Study (SWIFT)

Phase 2

Terminated

Conditions: Stroke

Interventions: Behavioral: interactive educational program
Behavioral: usual medical care

First Posted Date: 2006-12-22

Last Posted Date: 2013-02-18

Lead Sponsor: Columbia University

Target Recruit Count: 1635

Registration Number: NCT00415389

Locations: 🇺🇸
Neurological Institute, 710 W 168th Street, 6th Floor, Room 640, New York, New York, United States

Stem Cell Transplant in Sickle Cell Disease and Thalassemia

Phase 2

Active, not recruiting

Conditions: Sickle Cell Disease
Beta Thalassemia

Interventions: Drug: Busulfan
Drug: Fludarabine
Drug: Alemtuzumab
Procedure: Allogeneic stem cell transplant

First Posted Date: 2006-12-07

Last Posted Date: 2024-06-13

Lead Sponsor: Columbia University

Target Recruit Count: 53

Registration Number: NCT00408447

Locations: 🇺🇸
Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University, New York, New York, United States

Study of Carotid Occlusion and Neurocognition

Not Applicable

Completed

Conditions: Carotid Artery Diseases

Interventions: Procedure: EC-IC Bypass in the COSS study

First Posted Date: 2006-10-19

Last Posted Date: 2013-07-30

Lead Sponsor: Columbia University

Target Recruit Count: 294

Registration Number: NCT00390481

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

A Randomized Trial of Unruptured Brain AVMs

Phase 3

Completed

Conditions: Arteriovenous Malformations, Cerebral

Interventions: Procedure: Interventional therapy
Other: Medical management

First Posted Date: 2006-10-18

Last Posted Date: 2015-06-04

Lead Sponsor: Columbia University

Target Recruit Count: 226

Registration Number: NCT00389181

Locations: 🇦🇹
Universitätsklinik für Neurologie, Anichstrasse 35, 6020 Innsbruck, Innsbruck, Austria
🇦🇺
Austin Health, University of Melbourne 300 Waterdale Rd,Heidelberg Heights, Melbourne, Victoria, Australia
🇫🇮
Helsinki University Central Hospital, Dept. of Neurosurgery, Topeliuksenkatu 5, Helsinki, P.O. Box 266, Helsinki, Finland

and more 63 locations

Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)

Phase 4

Completed

Conditions: Post Operative Pain

Interventions: Drug: Hydromorphone PCA
Drug: Morphine PCA

First Posted Date: 2006-10-09

Last Posted Date: 2018-08-14

Lead Sponsor: Columbia University

Target Recruit Count: 50

Registration Number: NCT00385541

Locations: 🇺🇸
Columbia Presbyterian Hospital, New York, New York, United States

Nicotine as an Adjuvant Analgesic for Third Molar Surgery

Phase 4

Completed

Conditions: Dental Crowding

Interventions: Drug: Nicotine
Other: Placebo

First Posted Date: 2006-10-09

Last Posted Date: 2020-11-24

Lead Sponsor: Columbia University

Target Recruit Count: 20

Registration Number: NCT00385216

Locations: 🇺🇸
Columbia University, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy